(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.14% $ 5.32
@ $6.92
Ausgestellt: 14 Feb 2024 @ 20:05
Rendite: -23.07%
Vorheriges Signal: Feb 14 - 15:30
Vorheriges Signal:
Rendite: -1.07 %
Live Chart Being Loaded With Signals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally...
Stats | |
---|---|
Tagesvolumen | 512 701 |
Durchschnittsvolumen | 920 458 |
Marktkapitalisierung | 392.60M |
EPS | $0 ( 2024-02-27 ) |
Nächstes Ertragsdatum | ( $0.0400 ) 2024-05-08 |
Last Dividend | $1.600 ( 1998-01-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 7.39 |
ATR14 | $0.00300 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-26 | Datin James A | Buy | 3 217 | Common Stock |
2024-03-26 | Datin James A | Sell | 871 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Buy | 58 759 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Sell | 5 616 | Common Stock |
2024-03-01 | Anthony Michele Marie | Buy | 24 336 | Common Stock |
INSIDER POWER |
---|
67.98 |
Last 97 transactions |
Buy: 2 719 008 | Sell: 297 058 |
Volumen Korrelation
OraSure Technologies Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
OraSure Technologies Inc Korrelation - Währung/Rohstoff
OraSure Technologies Inc Finanzdaten
Annual | 2023 |
Umsatz: | $405.47M |
Bruttogewinn: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2023 |
Umsatz: | $405.47M |
Bruttogewinn: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2022 |
Umsatz: | $387.48M |
Bruttogewinn: | $147.64M (38.10 %) |
EPS: | $-0.250 |
FY | 2021 |
Umsatz: | $233.67M |
Bruttogewinn: | $117.60M (50.33 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
OraSure Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.600 | 1998-01-08 |
Last Dividend | $1.600 | 1998-01-08 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1.600 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.02 | |
Div. Directional Score | 7.70 | -- |
Year | Amount | Yield |
---|---|---|
1998 | $1.600 | 29.80% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.35 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.111 | 1.200 | 6.30 | 7.56 | [0 - 0.3] |
returnOnEquityTTM | 0.132 | 1.500 | 9.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.77 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.36 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 7.35 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0280 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0314 | -1.500 | 9.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.425 | 1.000 | 6.26 | 6.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0901 | 1.000 | -0.198 | -0.198 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.840 | 0.800 | 7.73 | 6.19 | [0.5 - 2] |
Total Score | 11.37 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.29 | 1.000 | 9.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.132 | 2.50 | 9.77 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0486 | 1.500 | -3.01 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.286 | 1.000 | 5.36 | 0 | [0.1 - 0.5] |
Total Score | 4.02 |
OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.